DiscoverIn Good Company with Nicolai TangenRerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk
Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk

Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk

Update: 2024-07-241
Share

Description

Rerun:

“I'm very concerned that European citizens will have lack of access or much lower access to some of the new medicines” says CEO of Novo Nordisk. He also share some interesting perspectives about the importance of purpose and their new weight loss drug.

The production team on this episode were PLAN-B’s Niklas Figenschau Johansen and Nikolai Ovenberg. Background research was done by Sigurd Brekke with input from portfolio manager Gemma Game.





Hosted on Acast. See acast.com/privacy for more information.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk

Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk